SO
51
3
PWR
59
-8
SYY
50
2
PG
37
2
TAP
51
4
VMC
60
-2
SLG
60
4
MRK
45
2
RHI
27
2
BLK
69
5
EQT
54
4
BSX
63
-3
IP
64
2
APH
65
7
MCO
59
3
EIX
42
5
MTCH
53
2
NOV
40
-2
MCK
52
2
PM
52
2
SO
51
3
PWR
59
-8
SYY
50
2
PG
37
2
TAP
51
4
VMC
60
-2
SLG
60
4
MRK
45
2
RHI
27
2
BLK
69
5
EQT
54
4
BSX
63
-3
IP
64
2
APH
65
7
MCO
59
3
EIX
42
5
MTCH
53
2
NOV
40
-2
MCK
52
2
PM
52
2
Financhill
Back

Zevra Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

ZVRA
Zevra Therapeutics

Last Price:
$12.64
Seasonality Move:
11.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Zevra Therapeutics Stock Forecast

  • Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 13.5% based on the past 10 years of stock performance.
  • Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Zevra Therapeutics Stock Undervalued?
    The current Zevra Therapeutics [ZVRA] share price is $12.32. The Score for ZVRA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Zevra Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 13.5% based on the past 10 years of stock performance.

Zevra Therapeutics Stock Rating

Buy
56
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics overpriced?

  • Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Zevra Therapeutics Stock Price History

Is ZVRA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com

52-Week Data

52-Week High:
13.16
52-Week Low:
5.45

Prediction Charts

Market Cap:
673.7M
Price in USD:
12.32
Volume:
1.6M
Beta:
1.80

Technical Analysis

SMA50:
9.26
SMA100:
8.40
SMA200:
8.36
52-Wk Change:
88.38%

Stock Predictions

  • Is Zevra Therapeutics stock public?
    Yes, Zevra Therapeutics is a publicly traded company.
  • What is the Zevra Therapeutics stock quote today?
    The Zevra Therapeutics stock price is 12.32 USD today.
  • How to buy Zevra Therapeutics stock online?
    You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 9.30 9.28 9.39 9.11
Jun-27 9.25 9.00 9.25 8.89
Jun-30 9.03 8.81 9.07 8.81
Jul-1 8.71 8.95 8.95 8.58
Jul-2 9.25 9.41 9.63 9.00
Jul-3 9.41 9.74 10.03 9.29
Jul-7 9.78 11.27 11.50 9.77
Jul-8 11.31 11.55 11.59 11.06
Jul-9 11.73 11.56 11.84 11.48
Jul-10 11.94 12.02 12.37 11.75
Jul-11 12.09 12.53 12.55 11.89
Jul-14 12.67 12.79 12.90 12.34
Jul-15 12.79 12.79 13.16 12.54
Jul-16 12.83 12.32 12.89 12.17

Zevra Therapeutics Earnings

Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zevra Therapeutics Forecast Revenue Growth

Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.23 per share, an increase this year of $3.37 per share, and a decrease next year of $0.81 per share.

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.